Cited by

• Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.

  Yoshida K, Wada H, Hasegawa M, Wakabayashi H, Matsumoto T, Shimokariya Y, Noma K, Yamada N, Uchida A, Nobori T, Sudo A. Yoshida K, et al. Int J Hematol. 2012 Feb;95(2):160-6. doi: 10.1007/s12185-012-1004-2. Epub 2012 Jan 21. Int J Hematol. 2012. PMID: 22270404 Clinical Trial.
• Rational design of low-molecular weight heparins with improved in vivo activity.

  Sundaram M, Qi Y, Shriver Z, Liu D, Zhao G, Venkataraman G, Langer R, Sasisekharan R. Sundaram M, et al. Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):651-6. doi: 10.1073/pnas.252643299. Epub 2003 Jan 13. Proc Natl Acad Sci U S A. 2003. PMID: 12525684 Free PMC article.
• Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.

  Yoshida K, Wada H, Hasegawa M, Wakabayashi H, Ando H, Oshima S, Matsumoto T, Shimokariya Y, Noma K, Yamada N, Uchida A, Nobori T, Sudo A. Yoshida K, et al. Int J Hematol. 2011 Oct;94(4):355-360. doi: 10.1007/s12185-011-0933-5. Epub 2011 Sep 22. Int J Hematol. 2011. PMID: 21935756 Clinical Trial.
• Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.

  Mattsson C, Hoylaerts M, Holmer E, Uthne T, Collen D. Mattsson C, et al. J Clin Invest. 1985 Apr;75(4):1169-73. doi: 10.1172/JCI111812. J Clin Invest. 1985. PMID: 3988937 Free PMC article.
• American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

  Monagle P, Azzam M, Bercovitz R, Betensky M, Bhat R, Biss T, Branchford B, Brandão LR, Chan AKC, Faustino EVS, Jaffray J, Jones S, Kawtharany H, Kerlin BA, Kucine N, Kumar R, Male C, Pelland-Marcotte MC, Raffini L, Raulji C, Sartain SE, Takemoto CM, Tarango C, van Ommen CH, Velez MC, Vesely SK, Wiernikowski J, Williams S, Wilson HP, Woods G, Zia A, Mustafa RA. Monagle P, et al. Blood Adv. 2025 May 27;9(10):2587-2636. doi: 10.1182/bloodadvances.2024015328. Blood Adv. 2025. PMID: 40423983 Free PMC article.